Ryan Specialty (NYSE:RYAN) Issues Quarterly Earnings Results, Beats Estimates By $0.02 EPS

Ryan Specialty (NYSE:RYAN) released its quarterly earnings data on Thursday. The company reported $0.51 EPS for the quarter, topping the consensus estimate of $0.49 by $0.02, FiscalAI reports. The business had revenue of $789.96 million for the quarter, compared to analyst estimates of $792.99 million. Ryan Specialty had a net margin of 7.55% and a return on equity of 43.97%. During the same period in the previous year, the firm earned $0.47 EPS.

Here are the key takeaways from Ryan Specialty’s conference call:

• Third-quarter results remained resilient: revenue increased 4.7% to $790 million, organic growth was 4%, adjusted EBITDAC rose 3.8% to $244 million, and adjusted EPS grew 8.5% to $0.51 despite a difficult comparison.
• Market conditions are becoming more competitive, with continued property pricing declines, broader casualty competition, new capacity in delegated authority, and softness in builders risk. Management expects further property pricing deterioration in the fourth quarter and into 2027, while full-year adjusted EBITDAC margin is expected to decline modestly.
• Management raised its 2026 outlook for organic revenue growth to the higher end of its mid-single-digit range and cited cost discipline, Empower efficiencies, strong producer retention, and the eventual accretion of its late-2025 hiring class as margin and growth tailwinds.
• Ryan Specialty is expanding AI-related insurance offerings and internal automation, including a $625 million GPU facility and expanded transit coverage of up to $100 million per shipment. The company also repurchased $150 million of shares in the quarter and had $100 million remaining under its authorization.
• Management sees potential for a more active M&A environment in 2027 and continued growth in reinsurance, delegated authority, data-center infrastructure, and other complex specialty risks, supported by strong client demand and the company’s specialty distribution platform.

Ryan Specialty Stock Up 1.8%

RYAN traded up $0.78 during trading on Friday, reaching $44.06. The stock had a trading volume of 1,676,763 shares, compared to its average volume of 2,192,364. The company has a current ratio of 1.00, a quick ratio of 1.00 and a debt-to-equity ratio of 3.51. The stock’s 50 day moving average is $40.41 and its two-hundred day moving average is $39.20. Ryan Specialty has a one year low of $29.28 and a one year high of $58.94. The company has a market capitalization of $11.27 billion, a price-to-earnings ratio of 61.07, a P/E/G ratio of 0.87 and a beta of 0.61.

Ryan Specialty Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, November 24th. Investors of record on Tuesday, November 10th will be issued a dividend of $0.13 per share. This represents a $0.52 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date is Tuesday, November 10th. Ryan Specialty’s dividend payout ratio is currently 72.22%.

Ryan Specialty News Roundup

Here are the key news stories impacting Ryan Specialty this week:

• Positive Sentiment: Adjusted earnings beat expectations: Third-quarter EPS was $0.51, above the $0.49 consensus and up from $0.47 a year earlier. Revenue rose 4.7% to approximately $790 million, while net income increased 40.6% to $88 million. Ryan Specialty Q3 Earnings and Revenues Beat Estimates
• Positive Sentiment: Capital returned to shareholders: Ryan Specialty repurchased $150 million of stock and paid $23.7 million in dividends and distributions during the quarter. It also declared a quarterly dividend of $0.13 per share, equivalent to $0.52 annually and a yield of approximately 1.2%. Ryan Specialty Stock Rated Hold
• Positive Sentiment: New growth initiative: The company launched Tera Underwriters with $625 million of capacity, potentially expanding its specialty insurance platform and future revenue opportunities. Ryan Specialty Launches Tera Underwriters
• Neutral Sentiment: Full-year revenue outlook maintained: Management reaffirmed guidance for mid-single-digit organic revenue growth in 2026, suggesting business trends remain broadly on plan. Ryan Specialty Reports Third-Quarter Results
• Negative Sentiment: Growth and margins are under pressure: Organic growth slowed to 4% in the quarter, and management indicated that the 2026 adjusted EBITDAC margin could decline by roughly 50 basis points from the prior year. Revenue also fell slightly short of analyst estimates. Ryan Specialty Organic Growth Slows
• Negative Sentiment: Analyst stance remains cautious: Wall Street analysts currently rate Ryan Specialty “Hold,” which may limit upside given the stock’s elevated valuation and substantial leverage. Analyst Hold Rating

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the stock. Morgan Stanley increased their price objective on Ryan Specialty from $48.00 to $50.00 and gave the stock an “overweight” rating in a report on Wednesday, August 19th. UBS Group boosted their target price on Ryan Specialty from $50.00 to $55.00 and gave the stock a “buy” rating in a research report on Monday, August 3rd. Barclays lifted their price target on Ryan Specialty from $46.00 to $48.00 and gave the company an “overweight” rating in a research note on Friday, July 31st. Wolfe Research cut shares of Ryan Specialty from an “outperform” rating to a “peer perform” rating in a report on Thursday, July 9th. Finally, Cantor Fitzgerald lifted their price target on Ryan Specialty from $34.00 to $41.00 and gave the stock a “neutral” rating in a report on Monday, August 3rd. Eight investment analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Ryan Specialty has an average rating of “Hold” and an average price target of $52.03.

About Ryan Specialty

Ryan Specialty Holdings, Inc is a specialty insurance services company that provides wholesale brokerage, managing general underwriting and delegated authority solutions. The company works with retail insurance brokers, agents, carriers and other market participants to place and manage complex, specialty risks that may require specialized underwriting expertise or customized coverage.

Its business includes specialty insurance and reinsurance brokerage, underwriting management and insurance program administration.